Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

Also called NCT01363661

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 165 participants (enrolled count) (from the registry)
Sponsor
Therabel Pharma SA/NV (from the registry)
Registry
  • NCT NCT01363661
  • EudraCT 2011-000190-31
Other papers using this trial's data
  • Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial Atherosclerosis, 2015-06 DOI, PubMed 25875387

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01363661. Randomized; triple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2014-09 (actual). Results posted on 2014-09-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris
Acronym
MEDCOR
Condition
Stable Angina Pectoris
Condition
Atherosclerosis
Intervention (Drug)
Coruno
Intervention (Drug)
Placebo
Lead sponsor
Therabel Pharma SA/NV (class: industry)

Record details

Record id
cardio:ct-nct01363661
Content hash
36052200523ed6408f283241fe95a6a162c6ba494fe9e7a57ad93ec5a67854c2